Penn Medicine News Blog Archive: Cancer

Decisions in Breast Reconstruction

By Katie Delach | July 17, 2015 | Comments image from http://s3.amazonaws.com/hires.aviary.com/k/mr6i2hifk4wxt1dp/15071717/2e8fc082-0df6-44ed-9004-a26fac33b49b.png

Autologous tissue reconstruction (left) and breast reconstruction using a tissue expander (right) are two of the most common reconstruction procedures following breast cancer treatment. Like many cancer patients, those facing a breast cancer diagnosis have a lot of decisions to make, and recovery is a long process. But unlike some... Read more

A Mutation, a New Drug, and a New Life

By Steve Graff | July 10, 2015 | Comments IMG_2462_large

Lois Hahn couldn’t have been happier on Tuesday. The 71-year-old wife and grandmother was back at Penn’s Abramson Cancer Center, with her son and husband by her side, for a follow-up visit with her medical oncologist, Alexander Perl, MD, an assistant professor of Hematology/Oncology in the ACC. She’s feeling and... Read more

When Less is Just Right

By Olivia Fermano | June 23, 2015 | Comments Ford-labcoat

Philadelphia is chock full of historical firsts, including in the field of medicine. Just last month, two of Penn Medicine’s big “firsts” celebrated their birthdays: the Perelman School of Medicine at the University of Pennsylvania – the nation’s first medical school – turned 250 and Pennsylvania Hospital, the nation’s first... Read more

Buzz Around Immunotherapy Continues at ASCO

By Steve Graff | June 5, 2015 | Comments Twitter

I read a very witty and apt tweet at this week’s American Society of Clinical Oncology (ASCO) annual meeting—the medical conference attended by over 30,000 oncologists and others in the field from all over the world: “Immunotherapy is like the hashtag—it’s here to stay.” The pithy 100 or so characters—replete... Read more

250 Years of Progress, Here's to 250 More

By Robert Press | May 26, 2015 | Comments

A whole lot can happen in 250 years. That’s partially because — and I guess this isn’t much of a surprise — 250 years is a long time. Long enough for a standard snail to circle the globe about 2.64 times (seriously, I did the math). Long enough for Niagara... Read more

Beyond Skin Deep: How Scars Affect Psychosocial Well-Being

By Katie Delach | May 18, 2015 | Comments Laser-for-scars-face-body2

Americans spend more than $12 billion per year on cosmetic procedures to enhance their appearance, whether it’s tanning, implanting, nipping or tucking. That’s because physical appearance influences nearly every aspect of our lives. And it’s not all our own insecurities or judgments, either. Studies show that strangers who observe photographs... Read more

The New Avengers: Lab-Coated Heroes Honored for Behind-the-Scenes Contributions

By Karen Kreeger | May 5, 2015 | Comments Lab week 2015 logo

Late last month Penn Medicine observed the fortieth Medical Laboratory Professionals Week, a time to recognize the hard work and dedication of the 600-plus lab professionals in more than 30 laboratories across the health system. Read more

Roberts Proton Therapy Center Celebrates 5 Years (Photos)

By Steve Graff | April 23, 2015 | Comments 15

Congratulations to the Roberts Proton Therapy Center on its five year anniversary! On Wednesday night, the department of Radiation Oncology held an event in the Smilow Center for Translational Research to celebrate this significant milestone with faculty, staff, Penn Medicine leadership, patients and their families, and the Roberts family, including... Read more

Removing Barriers to Breast Cancer Care

By Olivia Fermano | February 13, 2015 | Comments image from http://s3.amazonaws.com/hires.aviary.com/k/mr6i2hifk4wxt1dp/15021321/9c9ef157-fe05-4d2c-85e5-28de26e2480c.png

I overheard a breast cancer patient once say: There is only one thing worse than having cancer – not being able to afford it. Sobering. Financial cost remains a barrier to cancer screenings - let alone cancer treatment - among lower income women. While multiple factors contribute to racial and... Read more

Focus on Rare Diseases is Common at Penn Medicine

By Karen Kreeger | February 6, 2015 | Comments Rare Disease Day Logo 2015

Penn Medicine has been at the forefront of rare disease research for decades, and these efforts – as well as many of its other research and clinical milestones -- are being honored this year as part of the Perelman School of Medicine’s 250th anniversary celebration. Read more

Beyond Cancer: When Both Parents Hold BRCA, a New Risk Can Emerge

By Karen Kreeger | January 14, 2015 | Comments Greenberg Cancer Discovery blog post image

Greenberg Cancer Discovery blog post imageMany families are acutely aware that BRCA1 and BRCA2 are the most important breast and ovarian cancer susceptibility genes. But recently a team including researchers at Penn Medicine discovered another risk it can pose in cancer patients when both parents carry the mutation. Read more

Year in Review: A Look Back at 2014!

By Steve Graff | December 31, 2014 | Comments

Before we ring in the New Year, the Penn Medicine department of Communications is taking a look back at 2014, a year filled with more breakthroughs in medical research, growth at the Penn Medicine campus, and philanthropic support. This year, we took a different approach and put together a year...

Using Collaboration and Innovation to Counteract Flat Federal Research Funding

By Karen Kreeger | December 18, 2014 | Comments Light bulb by shuttermonkey via Flickr

With such astounding shortfalls in funding for biomedical research, Penn Medicine, a key stakeholder of the new Penn Center for Innovation (PCI), is looking for fresh ways to fund research and partner with the private sector. The PCI consolidates and unifies the enterprise previously known as the Penn Center for Technology Transfer with other campus entities charged with commercializing Penn research and Development into license agreements, sponsored research agreements, startup companies and other collaborative relationships. Read more

Making Better Sense of Acute Myeloid Leukemia

By Steve Graff | December 10, 2014 | Comments AML-M1

Acute myeloid leukemia (AML) is one of those cancers so genetically complex, with its many chromosomal abnormalities and mutations, that it has been hard for doctors to find clinically meaningful information to sort out this diversity. So when three gene sequencing studies from Penn Medicine show patterns that may help... Read more

Looking for Answers in the Genes of ‘Exceptional’ Cancer Patients

By Steve Graff | December 1, 2014 | Comments Bile duct cancer

The little-known metastatic bile duct cancer—or cholangiocarcinoma—is one of the toughest cancers out there to beat. It’s usually caught late and requires an aggressive round of chemotherapy and radiation that, in most cases, only stabilizes it briefly. It can come roaring back and often leads to death. But that wasn’t... Read more

Penn Medicine Day in the Life 2014

By Robert Press | November 12, 2014 | Comments

It’s fall, and with fall come a few annual traditions: the leaves changing color, pumpkin spice everything, Christmas decorations a full two months early, and — most relevant to us here at Penn Medicine — the Day in the Life project. It’s a yearly visual documentation of life here at... Read more

The Future of Telemedicine is Here

By Katie Delach | October 9, 2014 | Comments image from http://s3.amazonaws.com/hires.aviary.com/k/mr6i2hifk4wxt1dp/14101416/dea91fca-1943-42dc-a0fe-b26e31c313e0.png

Over the past 20 years, advancements in research and the understanding of genetics have created a boom in patient demand for genetic tests. According to the National Library of Medicine, less than 300 genetic tests were available in the 1990s; in contrast, at the end of 2012, almost 3,000 genetic... Read more

Detecting Lung Cancer Before It's Too Late

By Lee-Ann Donegan | October 3, 2014 | Comments image from http://s3.amazonaws.com/hires.aviary.com/k/mr6i2hifk4wxt1dp/14100317/5e5113a7-1b64-4023-b32e-78e3a593ddcd.png

Anil Vachani, MD, director of the Lung Nodule Program and assistant professor of Medicine at the Hospital of the University of Pennsylvania and the Veteran's Administration Medical Center; Attending Physician, Philadelphia Veterans Administration Medical Center. Lung cancer is the deadliest of all cancers, and cigarette smoking causes 85 percent of... Read more

How a Fish-Killing Natural Product Opens Doors to the Basics of Cell Metabolism

By Karen Kreeger | October 1, 2014 | Comments Blair Rotenone pic Oct 14

Rotenone exposure is also associated with Parkinson’s disease (PD) in humans, but the exact mechanism is unknown. In fact, rotenone is used to induce a rodent model of PD. Mitochondrial abnormalities have been well documented in PD patients, often coinciding with elevated markers of oxidative stress. Despite this evidence, not much is known about how nerve cells die because of the stress. Read more

The Art of War Against Cancer

By Olivia Fermano | September 23, 2014 | Comments image from http://s3.amazonaws.com/hires.aviary.com/k/mr6i2hifk4wxt1dp/14092319/ef10d5fc-5142-4b70-86f3-a4ca15afedd4.png

The Art of War, the military treatise attributed to the ancient Chinese general Sun Tzu, has influenced more than warfare since it was written over 2,000 years ago. Its principles have been applied to not only military strategies and tactics, but political, economic and legal ones as well. Today, Tzu's... Read more

Subscribe to Penn Medicine News Blog by Email

Search

Categories

Authors

About This Blog